In summary, FC‐1, a dual‐enzyme cascade‐activated probe, was designed to exploit the endogenous upregulation of FAPα and CTSC in cSCC, facilitating accurate differential diagnosis and therapeutic assessment of cSCC. Here, FAP is linked to skin squamous cell carcinoma.